Helder André

1.5k total citations
64 papers, 1.1k citations indexed

About

Helder André is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Helder André has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Ophthalmology, 33 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Helder André's work include Retinal Diseases and Treatments (29 papers), Glaucoma and retinal disorders (21 papers) and Angiogenesis and VEGF in Cancer (14 papers). Helder André is often cited by papers focused on Retinal Diseases and Treatments (29 papers), Glaucoma and retinal disorders (21 papers) and Angiogenesis and VEGF in Cancer (14 papers). Helder André collaborates with scholars based in Sweden, Spain and Italy. Helder André's co-authors include Anders Kvanta, Monica Aronsson, Effat Alizadeh, Sandra Petrus-Reurer, Hammurabi Bartuma, Teresa Pereira, Fredrik Lanner, Emma Lardner, Seppo Ylä‐Herttuala and Lorenz Poellinger and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Helder André

60 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helder André Sweden 20 602 427 200 198 83 64 1.1k
Hideo Kohno Japan 17 847 1.4× 608 1.4× 137 0.7× 136 0.7× 141 1.7× 36 1.3k
Wolfram Eichler Germany 23 735 1.2× 683 1.6× 93 0.5× 391 2.0× 137 1.7× 42 1.4k
Ling Luo China 17 413 0.7× 335 0.8× 60 0.3× 294 1.5× 68 0.8× 43 993
Xiaowu Gu United States 16 493 0.8× 199 0.5× 119 0.6× 65 0.3× 40 0.5× 24 1.1k
Yan-Nian Hui China 19 413 0.7× 571 1.3× 86 0.4× 533 2.7× 55 0.7× 74 1.0k
Zai‐Long Chi China 16 418 0.7× 282 0.7× 100 0.5× 87 0.4× 58 0.7× 37 782
Piroska E. Rakoczy Australia 17 1.0k 1.7× 876 2.1× 68 0.3× 365 1.8× 73 0.9× 39 1.5k
Kay D. Rittenhouse United States 16 427 0.7× 579 1.4× 43 0.2× 317 1.6× 32 0.4× 33 1.1k
Carol Merges United States 20 795 1.3× 1.1k 2.5× 42 0.2× 695 3.5× 76 0.9× 23 1.7k
M Ménasche France 16 489 0.8× 264 0.6× 52 0.3× 245 1.2× 51 0.6× 47 902

Countries citing papers authored by Helder André

Since Specialization
Citations

This map shows the geographic impact of Helder André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helder André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helder André more than expected).

Fields of papers citing papers by Helder André

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helder André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helder André. The network helps show where Helder André may publish in the future.

Co-authorship network of co-authors of Helder André

This figure shows the co-authorship network connecting the top 25 collaborators of Helder André. A scholar is included among the top collaborators of Helder André based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helder André. Helder André is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martins, Vívian T., Ricardo Andrez Machado‐de‐Ávila, Ana Maria Ravena Severino Carvalho, et al.. (2025). Synthetic peptides derived from hypothetical proteins as potential antigens for the diagnosis of canine visceral leishmaniasis and tegumentary leishmaniasis. Experimental Parasitology. 270. 108914–108914. 2 indexed citations
2.
Reyes, Álvaro Plaza, et al.. (2025). VEGF in Tears as a Biomarker for Exudative Age-Related Macular Degeneration: Molecular Dynamics in a Mouse Model and Human Samples. International Journal of Molecular Sciences. 26(8). 3855–3855. 1 indexed citations
3.
André, Helder, et al.. (2024). Prognostic implications of tenascin C in peripheral blood and primary tumours at the time of uveal melanoma diagnosis. Canadian Journal of Ophthalmology. 59(6). e749–e757. 2 indexed citations
4.
Kvanta, Anders, Nalini Rangaswamy, Karen Holopigian, et al.. (2024). Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial. Nature Communications. 15(1). 7438–7438. 7 indexed citations
5.
Kvanta, Anders, et al.. (2024). Accelerated maturation of ARPE ‐19 cells for the translational assessment of gene therapy. The FASEB Journal. 38(17). e70020–e70020. 1 indexed citations
6.
Pavone, Vincenzo, et al.. (2024). Mitigation of human iris angiogenesis through uPAR / LRP ‐1 interaction antagonism in an organotypic ex vivo model. The FASEB Journal. 38(5). e23533–e23533.
7.
André, Helder, et al.. (2023). Exploring the Potential of Wild Olive (Acebuche) Oil as a Pharm‐Food to Prevent Ocular Hypertension and Fibrotic Events in the Retina of Hypertensive Mice. Molecular Nutrition & Food Research. 68(3). e2200623–e2200623. 1 indexed citations
8.
9.
Lardner, Emma, et al.. (2023). A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival. BMC Cancer. 23(1). 277–277. 8 indexed citations
10.
Vestweber, Dietmar, Lena Claesson‐Welsh, Donald M. McDonald, et al.. (2023). Report from the 2023 workshop on endothelial permeability, edema and inflammation. Nature Cardiovascular Research. 2(12). 1120–1124. 1 indexed citations
11.
André, Helder, et al.. (2023). Obesity paradox in uveal melanoma: high body mass index is associated with low metastatic risk. British Journal of Ophthalmology. 108(4). bjo–2022. 1 indexed citations
12.
Melas, Philippe A., et al.. (2021). The monoamine stabilizer OSU6162 has anxiolytic-like properties and reduces voluntary alcohol intake in a genetic rat model of depression. Scientific Reports. 11(1). 11856–11856. 4 indexed citations
13.
Aronsson, Monica, Emma Lardner, Alfonso Mate, et al.. (2021). Echinomycin mitigates ocular angiogenesis by transcriptional inhibition of the hypoxia-inducible factor-1. Experimental Eye Research. 206. 108518–108518. 8 indexed citations
14.
Smith, Ross, Takeshi Ninchoji, Emma Gordon, et al.. (2020). Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin. eLife. 9. 71 indexed citations
15.
Reyes, Álvaro Plaza, Sandra Petrus-Reurer, Sara Padrell Sánchez, et al.. (2020). Identification of cell surface markers and establishment of monolayer differentiation to retinal pigment epithelial cells. Nature Communications. 11(1). 1609–1609. 27 indexed citations
16.
André, Helder, et al.. (2019). The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective. Cellular and Molecular Life Sciences. 77(5). 819–833. 60 indexed citations
17.
Ögmundsdóttir, Margrét H., et al.. (2018). Microphthalmia-associated transcription factor (Mitf) modulates autophagy in mouse primary RPE cells. Investigative Ophthalmology & Visual Science. 59(9). 4020–4020. 1 indexed citations
18.
Aronsson, Monica, et al.. (2018). Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis. Journal of Visualized Experiments. 4 indexed citations
19.
Kvanta, Anders, et al.. (2016). Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis. Acta Ophthalmologica. 94(8). 805–814. 22 indexed citations
20.
André, Helder & Teresa Pereira. (2008). Identification of an Alternative Mechanism of Degradation of the Hypoxia-inducible Factor-1α. Journal of Biological Chemistry. 283(43). 29375–29384. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideo Kohno Breakdown of academic impact, for papers by Wolfram Eichler Breakdown of academic impact, for papers by Ling Luo Breakdown of academic impact, for papers by Xiaowu Gu Breakdown of academic impact, for papers by Yan-Nian Hui Breakdown of academic impact, for papers by Zai‐Long Chi Breakdown of academic impact, for papers by Piroska E. Rakoczy Breakdown of academic impact, for papers by Kay D. Rittenhouse Breakdown of academic impact, for papers by Carol Merges Breakdown of academic impact, for papers by M Ménasche
Rankless by CCL
2026